Are low levels of 25(OH) vitamin D and testosterone clinically relevant in men with paraplegia?

References

• Hummel K, Craven BC, Giangregorio L. Serum 25(OH)D, PTH and correlates of suboptimal 25(OH)D levels in persons with chronic spinal cord injury. Spinal Cord 2012;50(11):812–6. doi: 10.1038/sc.2012.67
   PubMed Web of Science ®Google Scholar
• Barbonetti A, Vassallo MR, Felzani G, Francavilla S, Francavilla F. Association between 25(OH)-vitamin D and testosterone levels: Evidence from men with chronic spinal cord injury. J Spinal Cord Med 2016;39(3).
   Google Scholar
• Bauman WA, La Fountaine MF, Spungen AM. Age-related prevalence of low testosterone in men with spinal cord injury. J Spinal Cord Med 2014;37(1):32–9. doi: 10.1179/2045772313Y.0000000122
   PubMed Web of Science ®Google Scholar
• Morley JE. Vitamin D redux. J Am Med Dir Assoc 2009;10(9):591–2. doi: 10.1016/j.jamda.2009.08.013
   PubMed Web of Science ®Google Scholar
• Yousefzadeh P, Shapses SA, Wang X. Vitamin D binding protein impact on 25-hydroxyvitamin D levels under different physiologic and pathologic conditions. Int J Endocrinol 2014; 2014;981581. Doi: 10.1155/2014/0981561. Epub 2014, April 28.
   PubMed Web of Science ®Google Scholar
• Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 2013;369(21):1991–2000. doi: 10.1056/NEJMoa1306357
   PubMed Web of Science ®Google Scholar
• Perry HM 3rd, Horowitz M, Morley JE, Patrick P, Vellas P, Baumgartner R, Garry PJ. Longitudinal changes in serum 25-hydroxyvitamin D in older people. Metabolism 1999;48(8):1028–32. doi: 10.1016/S0026-0495(99)90201-9
   PubMed Web of Science ®Google Scholar
• Michaëlsson K, Melhus H, Warensjö Lemming E, Wolk A, Byberg L. Long term calcium intake and rates of all cause and cardiovascular mortality: Community based prospective longitudinal cohort study. BMJ 2013; Feb 12; 346:f228.
   PubMed Web of Science ®Google Scholar
• Morley JE. Dementia: Does vitamin D modulate cognition? Nat Rev Neurol 2014;10(11):613–4. doi: 10.1038/nrneurol.2014.193
   PubMed Web of Science ®Google Scholar
• Mizutani S, Sonoda T, Matsumoto K, Iwasa K. Plasma testosterone concentration in paraplegic men. J Endocrinol 1972;54(2):363–4. doi: 10.1677/joe.0.0540363
   PubMed Web of Science ®Google Scholar
• Hayes PJ, Krishnan KR, Diver MJ, Hipkin LJ, Davis JC. Testicular endocrine function in paraplegic men. Clin Endocrinol (Oxf) 1979;11(5):549–52. doi: 10.1111/j.1365-2265.1979.tb03107.x
   PubMed Web of Science ®Google Scholar
• Morley JE, Distiller LA, Lissoos I, Lipschitz R, Kay G, Searle DL, et al. Testicular function in patients with spinal cord damage. Horm Metab Res 1979;11(12):679–82. doi: 10.1055/s-0028-1092799
   PubMed Web of Science ®Google Scholar
• Bauman WA, Cirnigliaro CM, La Fountaine MF, Jensen AM, Wecht JM, Kirshblum SC, et al. A small-scale clinical trial to determine the safety and efficacy of testosterone replacement therapy in hypogonadal men with spinal cord injury. Horm Metab Res 2011;43(8):574–9. doi: 10.1055/s-0031-1280797
   PubMed Web of Science ®Google Scholar
• Gray KM, Derosa A. Subcutaneous pellet testosterone replacement therapy: The “first steps” in treating men with spinal cord injuries. J Am Osteopath Assoc 2013;113(12):921–5. doi: 10.7556/jaoa.2013.071
   PubMedGoogle Scholar
• Kim MJ, Morley JE. The hormonal fountains of youth: Myth or reality? J Endocrinol Invest 2005;28(11 Suppl Proceedings):5–14.
   PubMedGoogle Scholar
• Chahla EJ, Hayek ME, Morley JE. Testosterone replacement therapy and cardiovascular risk factors modification. Aging Male 2011;14(2):83–90. doi: 10.3109/13685538.2010.541538
   PubMed Web of Science ®Google Scholar
• Goodman N, Guay A, Dandona P, Dhindsa S, Faiman C, Cunningham GR; AACE Reproductive Endocrinology Scientific Committee. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of testosterone and cardiovascular risk. Endocr Pract 2015;21(9):1066–73. doi: 10.4158/EP14434.PS
   PubMed Web of Science ®Google Scholar
• Barbonetti A, Caterina Vassallo MR, Cotugno M, Felzani G, Grancavilla S, Francavilla F. Low testosterone and non-alcoholic fatty liver disease: Evidence for their independent association in men with chronic spinal cord injury. J Spinal Cord Med 2015; Jan 23 (Epub ahead of print].
   PubMedGoogle Scholar
• Gaspar AP, Brandão CM, Lazaretti-Castro M. Bone mass and hormone analysis in patients with spinal cord injury: Evidence for a gonadal axis disruption. J Clin Endocrinol Metab 2014;99(12):4649–55. doi: 10.1210/jc.2014-2165
   PubMed Web of Science ®Google Scholar
• Morley JE, Kaiser FE, Perry HM 3rd, Patrick P, Morley PM, Stauber PM, et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 1997;46(4):410–3. doi: 10.1016/S0026-0495(97)90057-3
   PubMed Web of Science ®Google Scholar
• Zanatta L, Zamoner A, Zanatta AP, Bouraïma-Lelong H, Delalande C, Bois C, et al. Nongenomic and genomic effects of 1a,25(OH)2 vitamin D3 in rat testis. Life Sci 2011;89(15–16):515–23. doi: 10.1016/j.lfs.2011.04.008
   PubMed Web of Science ®Google Scholar
• Pilz S, Frisch S, Koertke H, Kuhn J, Dreier J, Obermayer-Pietsch B, et al. Effect of vitamin D supplementation on testosterone levels in men. Horm Metab Res 2011;43(3):223–5. doi: 10.1055/s-0030-1269854
   PubMed Web of Science ®Google Scholar
• Jorde R, Grimnes G, Hutchinson MS, Kjaergaard M, Kamycheva E, Svartberg J. Supplementation with vitamin D does not increase serum testosterone levels in healthy males. Horm Metab Res 2013;45(9):675–81. doi: 10.1055/s-0033-1345139
   PubMed Web of Science ®Google Scholar
• Heijboer AC, Ooseterwerff M, Schroten NF, Eekhoff EM, Chel VG, de Boer RA, et al. Vitamin D supplementation and testosterone concentrations in male human subjects. Clin Endocrinol (Oxf) 2015;83(1):105–10. doi: 10.1111/cen.12711
   PubMed Web of Science ®Google Scholar